Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension (Q48849818)

16 February 2018

title

Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension (English)

1 reference

16 February 2018

1 reference

Juan Carlos Yugar-Toledo

8

1 reference

16 February 2018

author name string

Rodrigo C Santos

1

1 reference

16 February 2018

Ana Paula C de Faria

2

1 reference

16 February 2018

Natália R Barbaro

3

1 reference

16 February 2018

Rodrigo Modolo

4

1 reference

16 February 2018

Silvia E Ferreira-Melo

5

1 reference

16 February 2018

José R Matos-Souza

6

1 reference

16 February 2018

Otávio R Coelho

7

1 reference

16 February 2018

Vanessa Fontana

9

1 reference

16 February 2018

David Calhoun

10

1 reference

16 February 2018

Heitor Moreno

11

1 reference

16 February 2018

publication date

24 November 2013

1 reference

16 February 2018

European Journal of Clinical Pharmacology

published in

1 reference

16 February 2018

volume

70

1 reference

16 February 2018

issue

2

1 reference

16 February 2018

page(s)

147-154

1 reference

16 February 2018

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

cites work

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Brain natriuretic peptide as a cardiac hormone in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Aldosterone excess or escape: Treating resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Cardiac Uses of Phosphodiesterase-5 Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Blood pressure lowering effects of a new long-acting inhibitor of phosphodiesterase 5 in patients with mild to moderate hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Sildenafil preserves diastolic relaxation after reduction by L-NAME and increases phosphodiesterase-5 in the intercalated discs of cardiac myocytes and arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Cardiovascular effects of phosphodiesterase 5 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2 current in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Phosphodiesterase type 5: expanding roles in cardiovascular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Erythrocytes are the major intravascular storage sites of nitrite in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

The measurement of blood and plasma nitrite by chemiluminescence: pitfalls and solutions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

I posicionamento brasileiro sobre hipertensão arterial resistente

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00228-013-1611-8

Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure

21 January 2018

1 reference

12 December 2020

Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension

1 reference

12 December 2020

Effect of regular phosphodiesterase type 5 inhibition in hypertension

1 reference

12 December 2020

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

1 reference

12 December 2020

Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries

1 reference

12 December 2020

The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients

1 reference

12 December 2020

10.1007/S00228-013-1611-8

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018